FBXW7 and neoplasm: To date, only a few studies have shown that FBXW7 interferes with the regulation of CSCs or tumor initiation cells, such as colorectal CSCs, gastric CSCs, and non-small-cell lung CSCs, and has a negative correlation with clinical recurrence and chemotherapy resistance [43–46].